Skip to main content
. 2018 Oct 24;9(6):531–539. doi: 10.3892/br.2018.1164

Table IV.

High-frequency allele subtypes of MS patients vs. control subjects.

HLA-ABDR allele MS group frequency, %, n=50 Control group frequency, %, n=50 P-value Odds ratio 95% confidence interval Pc
A19
  A29 4 6 0.516 1.532 0.419–5.603
  A30 8 3 0.120 2.812 0.724–10.924
  A31 2 0 0.490
  A32 9 9 1 1 0.379–2.634
  A33 3 2 1 1.516 0.248–9.271
A2 20 17 0.583 1.221 0.597–2.497
A9
  A23 4 3 0.999 1.347 0.294–6.180
  A24 16 5 0.011 3.619 1.271–10.303 0.022
B35 12 3 0.015 4.409 1.204–16.141 0.345
B40 7 3 0.195 2.434 0.611–9.694
  B60 1 0 1
  B61 2 1 1 2.020 0.180–22.646
B5
  B51 14 7 0.106 2.163 0.834–5.612
  B52 3 7 0.194 2.434 0.611–9.694
DR3
  DR17 15 15 1 1 0.460–2.173
  DR18 2 1 1 2.020 0.180–22.646
DR4 16 11 0.300 1.541 0.676–3.512
DR5
  DR11 15 11 0.399 1.428 0.621–3.284

HLA, human leukocyte antigen; MS, multiple sclerosis; Pc, corrected P-value.